Time to revisit warfarin pharmacogenetics. - Wikidata - awgldk - TriplyDB

Time to revisit warfarin pharmacogenetics.

Time to revisit warfarin pharmacogenetics.

http://www.wikidata.org/entity/Q47920440

about

Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients

P2860

Q58558658-1E652B0C-BC3A-463D-B698-305153BAC64C

P2860

Time to revisit warfarin pharmacogenetics.

http://www.wikidata.org/entity/Q47920440

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Time to revisit warfarin pharmacogenetics.

@en

Time to revisit warfarin pharmacogenetics.

@nl

type

label

Time to revisit warfarin pharmacogenetics.

@en

Time to revisit warfarin pharmacogenetics.

@nl

prefLabel

Time to revisit warfarin pharmacogenetics.

@en

Time to revisit warfarin pharmacogenetics.

@nl

P1433

Q47920440-8FB35777-1CD5-443A-A2F7-5ED325805469

P1476

Q47920440-30E3B7EF-A6B8-4D5B-96B3-A28B9FFC6BB4

P2093

Q47920440-B1820D47-D7DD-45D7-81C5-1FD4F7C14198

P2860

Q47920440-002C03DB-232D-42E8-8D70-325EE53364E1

Q47920440-307171A5-AE79-4104-AA56-F97FBEDBCF16

Q47920440-37748894-7717-4463-BEFC-773B72FF3791

Q47920440-5AD107B5-7E6A-4EBB-BB01-A3814BBB4C9E

Q47920440-63D7DE7D-AE1F-4BD7-95A6-B49DF2350EFD

Q47920440-7016B022-1C9D-4A20-8DBB-4C282CE2E973

Q47920440-86944FED-AF3B-413B-B318-27E3CF0765BB

Q47920440-93B82F76-F8FA-4E5A-AB90-A76FDF67F952

Q47920440-A2624F64-78E9-4AF1-AC40-CDC1D45AA7B8

Q47920440-A92DC14A-F922-49A2-A6E4-A81148FBFE11

P304

Q47920440-F0B5D6CB-644B-42C5-B238-B7F29081DB39

P31

Q47920440-6a8a31f7-6b7d-4dbf-a89e-dc96a40591da

Q47920440-761B1B2B-BFB4-4925-A5A4-691E6E9F16FA

P356

Q47920440-3046CB29-B4AC-4557-A53A-A3F5B433527A

P433

Q47920440-5829D769-4FEC-4586-824E-6984AD7D9893

P478

Q47920440-260E3967-1BA0-4355-AA0C-455814C52D35

P577

Q47920440-A75D4DC0-0844-423B-B85B-02B7FB7E8051

P698

Q47920440-7944C917-8DD6-4C39-9497-225096C8A866

P356

P1433

Future Cardiology

P1476

Time to revisit warfarin pharmacogenetics.

@en

P2093

Larisa H Cavallari

http://www.w3.org/2001/XMLSchema#string

P2860

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.

Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design.

The future of warfarin pharmacogenetics in under-represented minority groups.

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.

A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Feasibility of implementing a comprehensive warfarin pharmacogenetics service

Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.

Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach.

P304

511-513

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FCA-2017-0061

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28967279

http://www.w3.org/2001/XMLSchema#string